JPWO2023118576A5 - - Google Patents

Info

Publication number
JPWO2023118576A5
JPWO2023118576A5 JP2024535200A JP2024535200A JPWO2023118576A5 JP WO2023118576 A5 JPWO2023118576 A5 JP WO2023118576A5 JP 2024535200 A JP2024535200 A JP 2024535200A JP 2024535200 A JP2024535200 A JP 2024535200A JP WO2023118576 A5 JPWO2023118576 A5 JP WO2023118576A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
independently selected
halo
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535200A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500176A5 (https=
JP2025500176A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/087752 external-priority patent/WO2023118576A1/en
Publication of JP2025500176A publication Critical patent/JP2025500176A/ja
Publication of JP2025500176A5 publication Critical patent/JP2025500176A5/ja
Publication of JPWO2023118576A5 publication Critical patent/JPWO2023118576A5/ja
Pending legal-status Critical Current

Links

JP2024535200A 2021-12-23 2022-12-23 カルボン酸バイオアイソスタを含むdhodh阻害剤 Pending JP2025500176A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21217534 2021-12-23
EP21217534.3 2021-12-23
EP22201158 2022-10-12
EP22201158.7 2022-10-12
PCT/EP2022/087752 WO2023118576A1 (en) 2021-12-23 2022-12-23 Dhodh inhibitors containing a carboxylic acid bioisostere

Publications (3)

Publication Number Publication Date
JP2025500176A JP2025500176A (ja) 2025-01-09
JP2025500176A5 JP2025500176A5 (https=) 2026-01-06
JPWO2023118576A5 true JPWO2023118576A5 (https=) 2026-01-06

Family

ID=84981773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535200A Pending JP2025500176A (ja) 2021-12-23 2022-12-23 カルボン酸バイオアイソスタを含むdhodh阻害剤

Country Status (13)

Country Link
US (1) US20250066290A1 (https=)
EP (1) EP4452929A1 (https=)
JP (1) JP2025500176A (https=)
KR (1) KR20240130096A (https=)
AR (1) AR128080A1 (https=)
AU (1) AU2022422334B2 (https=)
CA (1) CA3240950A1 (https=)
IL (1) IL313501A (https=)
MX (1) MX2024007336A (https=)
PY (1) PY22111032A (https=)
TW (1) TW202332433A (https=)
UY (1) UY40087A (https=)
WO (1) WO2023118576A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202444688A (zh) 2023-03-29 2024-11-16 德商埃慕尼克股份公司 作為nurr1激動劑之維多氟地莫(vidofludimus)及相關結構
TW202506107A (zh) 2023-06-28 2025-02-16 德商埃慕尼克股份公司 雜芳族dhodh抑制劑
WO2026074007A1 (en) 2024-10-02 2026-04-09 Immunic Ag Nurr1 agonists with replacement of the carboxylic acid or carboxamide moiety for use in the treatment of neurodegenerative diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000224A (es) 2001-07-10 2005-07-25 4Sc Ag Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos.
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
EP1581478A1 (en) 2002-12-23 2005-10-05 4Sc Ag Dhodh-inhibitors and method for their identification
MXPA05006890A (es) 2002-12-23 2006-04-07 4Sc Ag Compuestos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
CN102271674A (zh) 2008-11-07 2011-12-07 4Sc股份公司 用于治疗自身免疫病的包含dhodh抑制剂和氨甲喋呤的联合治疗
TWI530286B (zh) * 2009-05-04 2016-04-21 帕納特斯製藥格斯有限公司 作為抑制病毒化合物之抗發炎劑
UA108760C2 (uk) 2010-07-01 2015-06-10 Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби
JP2016034901A (ja) 2012-11-26 2016-03-17 中外製薬株式会社 3,4−ジフルオロ−2−(2−フルオロ−4−ヨード−フェニルアミノ)−n−(2−ヒドロキシ−エトキシ)−5−(3−オキソ−[1,2]オキサジナン−2−イルメチル)−ベンズアミドの新規結晶形
KR102265277B1 (ko) 2014-04-11 2021-06-16 판옵테스 파르마 게스.엠.베.하. 바이러스 억제 화합물로서의 항-염증제
PL3139914T3 (pl) 2014-05-08 2023-11-27 Kiora Pharmaceuticals Gmbh Związki stosowane w leczeniu chorób i schorzeń okulistycznych
WO2018177151A1 (en) 2017-03-28 2018-10-04 Xiamen University Compounds modulating activity of farnesoid x receptor and methods for the use thereof
CN111343975A (zh) 2017-11-23 2020-06-26 埃慕尼克股份公司 用于预防或治疗慢性炎性疾病和/或自身免疫疾病的维多地莫的剂量方案
JP6804790B1 (ja) 2017-12-07 2020-12-23 エモリー ユニバーシティー N4−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
ES2972099T3 (es) 2018-03-09 2024-06-11 Kiora Pharmaceuticals Gmbh Formulación oftálmica
WO2019175396A1 (en) 2018-03-16 2019-09-19 Immunic Ag Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents

Similar Documents

Publication Publication Date Title
RU2010101611A (ru) Полициклические производные гуанина и способы их применения
RU2013132683A (ru) Ингибиторы репликации вирусов гриппа
JPWO2021092115A5 (https=)
RU2019118390A (ru) Производное пиразоло-гетероарила, способ его получения и медицинское применение
RU2013132717A (ru) Ингибиторы репликации вирусов гриппа
JP2017510644A5 (https=)
JP2012507522A5 (https=)
JP2010539110A5 (https=)
JP2010540508A5 (https=)
RU2005137276A (ru) Замещенные дигидрохиназолины с противовирусными свойствами
RU2018129849A (ru) 2-оксиндольные соединения
MA27390A1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
RU2002113750A (ru) Производные пиррола в качестве ингибиторов фосфодиэстеразы VII
RU2015135722A (ru) Дейтерированный фениламинопиримидин и фармацевтическая композиция, содержащая такое соединение
JP2017522339A5 (https=)
JPWO2023118576A5 (https=)
JP2017534591A5 (https=)
JPWO2022214691A5 (https=)
JP2019533007A5 (https=)
JPH04221327A (ja) スクアレンエポキシダーゼの抑制剤としてのスクアレンのジ−及びテトラ−フルオロ類似体類
RU2003110575A (ru) Производные пиразола, используемые в качестве ингибиторов ротеинкиназы
JPWO2021207530A5 (https=)
RU2002113746A (ru) Производные изоксазола в качестве ингибиторов фосфодиэстеразы VII
CN110483417A (zh) 一种DACOs类NNRTIs氨基酸酯衍生物、其制备方法、药物组合物及应用
JPWO2021092246A5 (https=)